Showing results (201-210 of 330) with videos related to

Sort By:
Pageof 33
Acta Biomaterialia|April 20, 2016
Protein resistance efficacy of PEO-silane amphiphiles: Dependence on PEO-segment length and concentrationMarc A Rufin, Mikayla E Barry, Paige A Adair, et al.
ACS Chemical Biology|June 6, 2013
A genetically encoded acrylamide functionalityYan-Jiun Lee, Bo Wu, Jeffrey E Raymond, et al.
Pharmaceutical Research|January 12, 2023
Mucopenetrating Janus Nanoparticles For Field-Coverage Oral Cancer ChemopreventionNahal Habibi, Caroline Bissonnette, Ping Pei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumoursJ Bennouna, P Fumoleau, J-P Armand, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 25, 2012
Arteriotomy closure device safety after percutaneous coronary intervention in the direct thrombin inhibitor era: a comparative studyGus Theodos, Chad Raymond, Matthew C Becker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patientsE Izbicka, R Lawrence, E Raymond, et al.
British Journal of Cancer|December 24, 2010
Single agent and combination studies of pralatrexate and molecular correlates of sensitivityM Serova, I Bieche, M-P Sablin, et al.
Anti-Cancer Drugs|October 19, 2000
Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude miceC Louvet, A M Coudray, C Tournigand, et al.
Bulletin Du Cancer|February 15, 2001
[Zd 1839 "Iressa"]J B Meric, S Faivre, C Monnerat, et al.
Oncoimmunology|December 10, 2020
PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinomaD Evrard, M Hourseau, A Couvelard, et al.
Pageof 33